Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in HIV Initiating ART
NCT05525156Phase 2Suspended
- Sponsor
- Muhimbili University of Health and Allied Sciences
- Start
- Mar 2020
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Aspirin Arm with Placebo Arm (2 arms). Primary endpoint: Proportion of participants attaining HVL of <50 copies/mL at 24 weeks. Started Mar 2020; status: suspended.
02
Drugs
aspirin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05525156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05525156.